Loading clinical trials...
Loading clinical trials...
The aim of this study is to evaluate the clinical efficacy and safety of MET after ESWL in pediatric urolithiasis.
Age
5 - 18 years
Sex
ALL
Healthy Volunteers
No
Urology and Nephrology Center
Al Mansurah, Egypt
Start Date
February 1, 2021
Primary Completion Date
December 1, 2023
Completion Date
December 1, 2023
Last Updated
March 10, 2023
120
ESTIMATED participants
Tamsulosin
DRUG
Placebo
DRUG
Lead Sponsor
Mansoura University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07052188